Asterion Inc. (“Asterion” or the “Company”), announces that its wholly-owned Australian subsidiary (“Asterion Australia”) has received its licences for the cultivation, manufacturing and research of medicinal cannab1s (the “Licences”) from the Australian Government’s Office of Drug Control (“ODC”), effective December 20, 2019.
Read more
Asterion Awarded Medicinal Cannabis Licences from the Australian Office of Drug Control
